AUTO4
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AUTO4, covering 2026-03-16 to 2026-03-16. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma [Phase 1, Phase 2]